InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by Hansen Carl L. G., Chairman & CEO. Officer active across 1 companies, notably AbCellera Biologics Inc.. Aggregated, 6 filings have been published. Total volume traded: €220.9m. The latest transaction was disclosed on 18 May 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€144,69756,125 shares@ €2.57810.012% mcap0.1% of flow
Common Shares
SEC:0001209191-22-030394:0·
€133,98956,125 shares@ €2.38730.011% mcap0.1% of flow
Common Shares
SEC:0001209191-22-013012:0·
€3m224,500 shares@ €13.2760.24% mcap2.6% of flow
Common Shares
SEC:0001209191-21-066133·
€3m224,500 shares@ €13.2760.24% mcap1.3% of flow
Common Shares
SEC:0001209191-21-066133:0·
€110m5,598,420 shares@ €19.72588.84% mcap97.4% of flow
Common Shares
SEC:0000899243-21-022993·
€110m5,598,420 shares@ €19.72588.84% mcap48.6% of flow
Common Shares
SEC:0000899243-21-022993:0·
6 of 6 declarations
About Hansen Carl L. G.
Carl L. G. Hansen is the Chief Executive Officer of AbCellera Biologics Inc. He is responsible for the strategic direction of the company and overall management of its operations. His role is essential in ensuring innovation and growth for AbCellera in the biotechnology sector.
